Anaheim, CANCT06846710Now EnrollingIRB Ready

Psoriasis Clinical Trial in Anaheim, CA

Access cutting-edge psoriasis treatment through this phase 1 clinical trial at a research site in Anaheim. Study-provided care at no cost to qualified participants.

Sponsored by Jiangsu Hansoh Pharmaceutical Co., Ltd.

Quick Self-Assessment

See if you qualify for this Anaheim location

Preparing your pre-screening questions…

Expert Care in Anaheim

Access psoriasis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related psoriasis treatment provided free

Apply for This Anaheim Location

Check if you qualify for this psoriasis clinical trial in Anaheim, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Anaheim

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Anaheim site if eligible
  4. 4Begin participation

About This Psoriasis Study in Anaheim

The study will be conducted in 2 parts (SAD for Part 1 and MAD for Part2). Part 1 is a single-center, randomized, double-blind, placebo-controlled, SAD study to evaluate the safety, tolerability, immunogenicity, and PK of HS-20118 after a single oral dose in healthy participants. Part 2 is a multi-center, randomized, double-blind, placebo-controlled, MAD study to evaluate the safety, tolerability, immunogenicity, PK, and PD of HS-20118 after multiple oral doses in patients with moderate to severe plaque psoriasis .

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.

Who Can Participate

Inclusion Criteria

For the SAD study:
Healthy adults aged 18-45 years (inclusive) at the time of signing the informed consent form;
Male participants weighing ≥ 50 kg and female participants weighing ≥ 45 kg, both ≤ 110 kg; body mass index (weight/square of height (kg/m2)) within the range of 18-28 kg/m2 (inclusive);
Normal results or abnormal results but without clinical significance in comprehensive examinations, including general physical examination, vital signs, laboratory tests, 12-lead ECG, abdominal color Doppler ultrasound, and chest X-ray from the frontal and lateral position ; For the MAD study:
Male or female participants aged 18-65 years (inclusive) at the time of signing the informed consent form;
Male participants weighing ≥ 50 kg and female participants weighing ≥ 45 kg, both ≤ 110 kg;
Chronic plaque psoriasis for at least 6 months with or without psoriatic arthritis;

Exclusion Criteria

For the SAD study:
Participants with immune-related diseases and medical history at screening;
Participants with a history of drug or other allergies who are considered by the investigator to be at high risk for participating in this study, or who may be allergic to the investigational medicinal product or any component of the investigational medicinal product as judged by the investigator;
History of drug abuse within the past 5 years or use of illicit drugs within 3 months before the study; or positive for urine drug screening; For the MAD study:
Guttate psoriasis, pustular psoriasis, erythrodermic psoriasis, drug-induced psoriasis, or other diseases that affect the treatment results;
Current use of illicit drugs or prior use of illicit drugs within the specific time periods;
Known history of recurrent or chronic infections, or prior history of chronic or recurrent infections, including but not limited to: chronic renal infection, chronic chest infection (e.g., bronchiectasis), symptomatic urinary tract infection, and open, draining, or infected skin wounds; history of serious infections (e.g., sepsis, pneumonia, and pyelonephritis), or hospitalization or treatment with intravenous antibiotics for infections within 2 months before screening;

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Anaheim?

Yes, this clinical trial (NCT06846710) has an active research site in Anaheim, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Psoriasis Treatment Options in Anaheim, CA

If you're searching for psoriasis treatment options in Anaheim, CA, this clinical trial (NCT06846710) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Anaheim research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced psoriasis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all psoriasis clinical trials near you to find additional studies recruiting in your area.

More Psoriasis Trials in Anaheim, CA

See all psoriasis clinical trials recruiting in Anaheim — not just this study.

Browse Psoriasis Trials in Anaheim →

Ready to Join in Anaheim?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Anaheim, CA